BPI and systemic sclerosis: Anti-BPI autoantibody levels are increased in patients with inflammatory diseases (such as systemic sclerosis and inflammatory bowel disease), whereas systemic sclerosis patients with high anti-BPI antibody levels show decreased skin inflammation in the absence of renal involvement 40.